Role of IFN-γ produced after intraperitoneal transplantation of AK-5 cells in the induction of Fas ligand expression by tumor cells leading to immune evasion

Journal of Interferon and Cytokine Research

Volumn 19, Issue 7, 1999, Pages 803-809

  Khar, Ashok ^a   Varalakshmi, C H ^a   Pardhasaradhi, B V V ^a   Kumari, A Leela ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; ASCITES FLUID; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EFFECTOR CELL; FLOW CYTOMETRY; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD95; ASCITES; CELL TRANSPLANTATION; COCULTURE TECHNIQUES; DOWN-REGULATION; INTERFERON TYPE II; LIGANDS; LYMPHOCYTE COUNT; PERITONEAL CAVITY; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0032800319     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313668     Document Type: Article

References (32)

1. NAGATA, S., and GOLDSTEIN, P. (1995). The Fas death factor. Science 267, 1449-1456.
2. RUSSELL, J.H., RUSH, B., WEAVER, C., and WANG, R. (1993). Mature T cells of autoimmune Ipr/Ipr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90, 4409-4412.
3. LOWIN, B., HAHNE, M., MATTMANN, C., and TSCHOPP, J. (1994). Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370, 650-652.
4. GRIFFITH, T., BRUNNER, T., FLETCHER, S., GREEN, D., and FERGUSON, T. (1995). Fas ligand induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
5. GRIFFITH, T., and FERGUSON, T. (1997). The role of Fas-L induced apoptosis in immune privilege. Immunol. Today 18, 240-244.
6. BELLGRAU, D., GOLD, D., SALAWRY, H., MOORE, J., FRANZUSOFF, A., and DUKE, R.C. (1995). A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632.
7. HUNT, J.S., VASSMER, D., FERGUSON, T.A., and MILLER, L. (1997). Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 158, 4122-4128.
8. DOWLING, P., SHANG. G., RAVEL. S., MENNONA. J., COOK, S., and HUSAR, W. (1996). Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184, 1513-1519.
9. MOLLER, P., WALCZAK, H., REIDL, S. STRÄTER. J., and KRAMMER, P.H. (1996). Paneth cells express high levels of CD95 ligand transcripts: a unique property among gastrointestinal epithelial. Am. J. Pathol. 149, 9-14.
10. STRAND, S., HOFMANN, W.J., HUG, H., MÜLLER, M., OTTO, G., STRAND, D., MARIANT, S.M., STREMMEL, W., KRAMMER, P.H., and GALLE, P.R. (1996). Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat. Med. 2, 1361-1366.
11. HAHNE, M., RIMOLDI, D., SCHROTER, M., ROMERO, P. SCHREIER, M., FRENCH, L.E., SCHNEIDER, P., BORNAND, T., FONTANA, A., LIENARD, D., CEROTTINI, J.-C., and TSCHOPP, J. (1996). Melanoma cell expression of Fas (APO-1/CD95) ligand: implications for tumor immune escape. Science 274, 1363-1366.
12. MARTINEZ-LORENZO, M.J., ALAVA, M.A., ANEL, A., PINEIRO, A., and NAVAL, J. (1996). Release of performed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 89, 511-517.
13. SUDA, T., HASHIMOTO, H., TANAKA, M., OCHI, T., and NAGATA, S. (1997). Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med. 186, 2045-2050.
14. KHAR, A. (1986). Development and characterization of a rat histiocyte/macrophage tumor line. J. Natl. Cancer Inst. 76, 871-877.
15. KHAR, A. (1993). Characterization of spontaneous immunological regression in a histiocytoma: I. Role of NK cels and antitumor antibodies. Int. J. Oncol. 2, 393-398.
16. KHAR, A., KUMARI, A.L., and ALI, A.M. (1993). Characterization of spontaneous immunological regression in histiocytoma: Ii. Participation of tumor necrosis factor. Int. J. Oncol. 2, 399-402.
17. KHAR, A., KAUSALYA, S., and KAMAL, M.A. (1996). AK-5 tumor induced modulation of host immune function: upregulauon of Th1 type of cytokine response mediates early tumor regression. Cytokines Mol. Ther. 2, 39-46.
18. NANDAKUMAR, K.S., LEELA KUMARI, A., and KHAR, A. (1997). Early expression of interleukin-12, p40 subunit and IFN-γ inhibits regression of AK-5 tumor. Cytokines Cell. Mol. Ther. 3, 225-232.
19. KHAR, A., VARALAKSHMI, CH., PARDHASARADHI, B.V.V., ALI, A.M., and KUMARI, A.L. (1998). Depletion of the natural killer cell population in the peritoneum by AK-5 tumor cells overexpressing Fas-ligand: a mechanism of immune evasion. Cell. Immunol. 189, 85-91.
20. KAUSALYA, S., VARALAKSHMI, CH., and KHAR, A. (1995). Correlation of in vivo and in vivo effects of IFN-γ with the spontaneous regression of a rat histiocytoma. J. Interferon Cytokine Res. 15, 647-654.
21. CHOMOZYNSKI, P., and SACCHI, N. (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
22. KOCH, J., KOLVRAA, S., and BOLUND, L. (1986). An improved method for labelling of DNA probes by nicktranslation. Nucleic Acids Res 14, 7132.
23. IJISSELMUDEN, O.E., HERBRINK, P., MEDDENS, M.J.M., TANK, B., STOLZ, E., and VAN ELTK, R.V.W. (1989). Optimizing the solid-phase immunofiltration assay. A rapid alternate to immunoassays. J. Immunol. Methods 119, 35-43.
24. GONG, J., TRAGANOS, F., and DARZYNKIEWICZ, Z. (1994). A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218, 314-319.
25. KAUSALYA, S., HEGDE, S.P., BRIGHT, J.J., and KHAR, A. (1994). Mechanism of antibody dependent natural killer cell-mediated AK-5 tumor cell death. Exp. Cell Res. 212, 285-290.
26. KHAR, A., PARDHASARADHI, B.V.V., VARALAKSHMI, CH., and ALI, A.M. (1997). Natural killer cell as the effector which mediates in vivo apoplosis in AK-5 tumor cells. Cell. Immunol. 177, 86-92.
27. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200.
28. KÄGI. D., VIGNAUX, F., LEDERMANN, B., BÜRKI, K., DEPRAETERE, V., NAGATA, S., HENGARTNER, H., and GOLSTEIN, P. (1994). Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528-530.
29. LYNCH, D.H., RAMSDELL, F., and ALDERSON, M.R. (1995). Fas and Fas-L in the homeostatic regulation of immune responses. Immunol. Today 16, 569-574.
30. YONEHARA, S., ISHII, A., and YONEHARA, H. (1989). A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
31. ABREU-MARTIN, M.T., VIDRICH, A., LYNCH, D.H., and TARGAN, S.R. (1995). Divergent induction of apoptosis and IL-8 secretion of HT-29 eels in response to TNF-α and ligand of Fas antigen. J. Immunol. 155, 4141-4154.
32. TANAKA, M., ITAI, T., ADACHI, M., and NAGATA, S. (1998). Downregulation of Fas ligand by shedding. Nat. Med. 4, 31-36.